Literature DB >> 19704072

Surgeon training, protocol compliance, and technical outcomes from breast cancer sentinel lymph node randomized trial.

David N Krag1, Takamaru Ashikaga, Seth P Harlow, Joan M Skelly, Thomas B Julian, Ann M Brown, Donald L Weaver, Norman Wolmark.   

Abstract

BACKGROUND: The National Surgical Adjuvant Breast and Bowel Project B-32 trial was designed to determine whether sentinel lymph node resection can achieve the same therapeutic outcomes as axillary lymph node resection but with fewer side effects and is one of the most carefully controlled and monitored randomized trials in the field of surgical oncology. We evaluated the relationship of surgeon trial preparation, protocol compliance audit, and technical outcomes.
METHODS: Preparation for this trial included a protocol manual, a site visit with key participants, an intraoperative session with the surgeon, and prerandomization documentation of protocol compliance. Training categories included surgeons who submitted material on five prerandomization surgeries and were trained by a core trainer (category 1) or by a site trainer (category 2). An expedited group (category 3) included surgeons with extensive experience who submitted material on one prerandomization surgery. At completion of training, surgeons could accrue patients. Two hundred twenty-four surgeons enrolled 4994 patients with breast cancer and were audited for 94 specific items in the following four categories: procedural, operative note, pathology report, and data entry. The relationship of training method; protocol compliance performance audit; and the technical outcomes of the sentinel lymph node resection rate, false-negative rate, and number of sentinel lymph nodes removed was determined. All statistical tests were two-sided.
RESULTS: The overall sentinel lymph node resection success rate was 96.9% (95% confidence interval [CI] = 96.4% to 97.4%), and the overall false-negative rate was 9.5% (95% CI = 7.4% to 12.0%), with no statistical differences between training methods. Overall audit outcomes were excellent in all four categories. For all three training groups combined, a statistically significant positive association was observed between surgeons' average number of procedural errors and their false-negative rate (rho = +0.188, P = .021).
CONCLUSIONS: All three training methods resulted in uniform and high overall sentinel lymph node resection rates. Subgroup analyses identified some variation in false-negative rates that were related to audited outcome performance measures.

Entities:  

Mesh:

Year:  2009        PMID: 19704072      PMCID: PMC2758311          DOI: 10.1093/jnci/djp281

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  10 in total

1.  Prerandomization Surgical Training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer.

Authors:  Seth P Harlow; David N Krag; Thomas B Julian; Takamaru Ashikaga; Donald L Weaver; Sheldon A Feldman; V Suzanne Klimberg; Roberto Kusminsky; Frederick L Moffat; R Dirk Noyes; Peter D Beitsch
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

2.  Standards of reporting of randomized controlled trials in general surgery: can we do better?

Authors:  Sabapathy P Balasubramanian; Martin Wiener; Zeiad Alshameeri; Ravindranath Tiruvoipati; Diana Elbourne; Malcolm W Reed
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

Review 3.  Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis.

Authors:  Theodore Kim; Armando E Giuliano; Gary H Lyman
Journal:  Cancer       Date:  2006-01-01       Impact factor: 6.860

4.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

5.  Clinical trials of surgical treatment of malignant diseases.

Authors:  Mitsuru Sasako
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

6.  Improved surgeon performance in clinical trials: an analysis of quality assurance audits from the American College of Surgeons Oncology Group.

Authors:  Y Nancy You; Lisa Jacobs; Elizabeth D Martinez; Susan C Budinger; E Jean Wittlief; Shelley K Myles; David M Ota
Journal:  J Am Coll Surg       Date:  2006-07-13       Impact factor: 6.113

7.  Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate.

Authors:  S L Wong; M J Edwards; C Chao; T M Tuttle; R D Noyes; D J Carlson; P B Cerrito; K M McMasters
Journal:  J Am Coll Surg       Date:  2001-06       Impact factor: 6.113

8.  Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

Authors:  David N Krag; Stewart J Anderson; Thomas B Julian; Ann M Brown; Seth P Harlow; Takamaru Ashikaga; Donald L Weaver; Barbara J Miller; Lynne M Jalovec; Thomas G Frazier; R Dirk Noyes; André Robidoux; Hugh M C Scarth; Denise M Mammolito; David R McCready; Eleftherios P Mamounas; Joseph P Costantino; Norman Wolmark
Journal:  Lancet Oncol       Date:  2007-10       Impact factor: 41.316

9.  The sentinel node in breast cancer--a multicenter validation study.

Authors:  D Krag; D Weaver; T Ashikaga; F Moffat; V S Klimberg; C Shriver; S Feldman; R Kusminsky; M Gadd; J Kuhn; S Harlow; P Beitsch
Journal:  N Engl J Med       Date:  1998-10-01       Impact factor: 91.245

10.  Re-emphasizing the concept of adequacy of intraoperative assessment of the axillary sentinel lymph nodes for identifying nodal positivity during breast cancer surgery.

Authors:  Stephen P Povoski; Donn C Young; Michael J Walker; William E Carson; Lisa D Yee; Doreen M Agnese; William B Farrar
Journal:  World J Surg Oncol       Date:  2007-02-09       Impact factor: 2.754

  10 in total
  5 in total

Review 1.  Breast cancer metastasis through the lympho-vascular system.

Authors:  S David Nathanson; David Krag; Henry M Kuerer; Lisa A Newman; Markus Brown; Dontscho Kerjaschki; Ethel R Pereira; Timothy P Padera
Journal:  Clin Exp Metastasis       Date:  2018-05-23       Impact factor: 5.150

2.  Manual Lymphatic Drainage after Subepidermal Tracer Injection Optimizes Results of Sentinel Lymph Node Labeling in Primary Breast Cancer.

Authors:  Martin Sillem; Urban Bromberger; Barbara Heitzelmann; Wolfgang J Brauer; Martin Werner; Sylvia Timme
Journal:  Breast Care (Basel)       Date:  2015-12-21       Impact factor: 2.860

3.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Authors:  David N Krag; Stewart J Anderson; Thomas B Julian; Ann M Brown; Seth P Harlow; Joseph P Costantino; Takamaru Ashikaga; Donald L Weaver; Eleftherios P Mamounas; Lynne M Jalovec; Thomas G Frazier; R Dirk Noyes; André Robidoux; Hugh Mc Scarth; Norman Wolmark
Journal:  Lancet Oncol       Date:  2010-10       Impact factor: 41.316

Review 4.  Axillary treatment for operable primary breast cancer.

Authors:  Nathan Bromham; Mia Schmidt-Hansen; Margaret Astin; Elise Hasler; Malcolm W Reed
Journal:  Cochrane Database Syst Rev       Date:  2017-01-04

5.  The Evolution of Axillary Staging in Breast Cancer.

Authors:  Roshni Rao
Journal:  Mo Med       Date:  2015 Sep-Oct
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.